Yamkamon V - Search Results

1

The BRCA1 3'-UTR: 5711+421T/T_5711+1286T/T genotype is a possible breast and ovarian cancer risk factor.

Pongsavee M, Yamkamon V, Dakeng S, O-charoenrat P, Smith DR, Saunders GF, Patmasiriwat P. Pongsavee M, et al. Among authors: yamkamon v. Genet Test Mol Biomarkers. 2009 Jun;13(3):307-17. doi: 10.1089/gtmb.2008.0127. Genet Test Mol Biomarkers. 2009. PMID: 19405875

2

A dual activation mechanism for Myb-responsive genes in myelomonocytic cells.

Yamkamon V, Ivanova O, Braas D, Chayka O, Patmasiriwat P, Klempnauer KH. Yamkamon V, et al. Blood Cells Mol Dis. 2008 Mar-Apr;40(2):219-26. doi: 10.1016/j.bcmd.2007.08.006. Epub 2007 Oct 18. Blood Cells Mol Dis. 2008. PMID: 17950008

3

Identification of a Myb-responsive enhancer of the chicken C/EBPbeta gene.

Kintscher J, Yamkamon V, Braas D, Klempnauer KH. Kintscher J, et al. Among authors: yamkamon v. Oncogene. 2004 Jul 29;23(34):5807-14. doi: 10.1038/sj.onc.1207722. Oncogene. 2004. PMID: 15195136

4

DNA detection of chronic myelogenous leukemia by magnetic nanoparticles.

Jangpatarapongsa K, Polpanich D, Yamkamon V, Dittharot Y, Peng-On J, Thiramanas R, Hongeng S, Jootar S, Charoenmak L, Tangboriboonrat P. Jangpatarapongsa K, et al. Among authors: yamkamon v. Analyst. 2011 Jan 21;136(2):354-8. doi: 10.1039/c0an00374c. Epub 2010 Oct 21. Analyst. 2011. PMID: 20963240

5

Colorimetric detection of PCA3 in urine for prostate cancer diagnosis using thiol-labeled PCR primer and unmodified gold nanoparticles.

Htoo KPP, Yamkamon V, Yainoy S, Suksrichavalit T, Viseshsindh W, Eiamphungporn W. Htoo KPP, et al. Among authors: yamkamon v. Clin Chim Acta. 2019 Jan;488:40-49. doi: 10.1016/j.cca.2018.10.036. Epub 2018 Oct 30. Clin Chim Acta. 2019. PMID: 30389454

6

Magnetic Nanoparticles PCR Enzyme-Linked Gene Assay for Quantitative Detection of BCR/ABL Fusion Gene in Chronic Myelogenous Leukemia.

Manthawornsiri Y, Polpanich D, Yamkamon V, Thiramanas R, Hongeng S, Rerkamnuaychoke B, Jootar S, Tangboriboonrat P, Jangpatarapongsa K. Manthawornsiri Y, et al. Among authors: yamkamon v. J Clin Lab Anal. 2016 Sep;30(5):534-42. doi: 10.1002/jcla.21899. Epub 2015 Dec 14. J Clin Lab Anal. 2016. PMID: 26667895 Free PMC article.

7

Urinary PCA3 detection in prostate cancer by magnetic nanoparticles coupled with colorimetric enzyme-linked oligonucleotide assay.

Yamkamon V, Htoo KPP, Yainoy S, Suksrichavalit T, Tangchaikeeree T, Eiamphungporn W. Yamkamon V, et al. EXCLI J. 2020 Apr 15;19:501-513. doi: 10.17179/excli2020-1036. eCollection 2020. EXCLI J. 2020. PMID: 32398974 Free PMC article.

8

Development of sarcosine quantification in urine based on enzyme-coupled colorimetric method for prostate cancer diagnosis.

Yamkamon V, Phakdee B, Yainoy S, Suksrichawalit T, Tatanandana T, Sangkum P, Eiamphungporn W. Yamkamon V, et al. EXCLI J. 2018 May 17;17:467-478. doi: 10.17179/excli2018-145. eCollection 2018. EXCLI J. 2018. PMID: 30034310 Free PMC article.

9

Simultaneous determination of sarcosine and its related metabolites by gas chromatography-tandem mass spectrometry for prostate cancer diagnosis.

Yamkamon V, Yee PP, Yainoi S, Eiamphungporn W, Suksrichavalit T. Yamkamon V, et al. EXCLI J. 2018 Oct 16;17:965-979. doi: 10.17179/excli2018-1352. eCollection 2018. EXCLI J. 2018. PMID: 30564076 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page